According to Regeneron Pharmaceuticals's latest financial reports the company's current EPS (TTM) is 37,31ย โฌ. In 2022 the company made an earnings per share (EPS) of 36,07ย โฌ a decrease over its 2021 EPS that were of 68,06ย โฌ.